Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Lentiviral Vector Market Growth in 2025?

In recent times, there has been rapid growth in the market size of lentiviral vectors. The market which is poised to grow from a value of $14.37 billion in 2024 to $16.62 billion in 2025, anticipates a compound annual growth rate (CAGR) of 15.7%. Factors such as the rising incidence of genetic disorders, the burgeoning demand for gene delivery, the expansion of biotech and pharma industries, investment in clinical trials, and regulatory approvals have largely contributed to the growth experienced during the historic period.

What Is the Forecast for the Lentiviral Vector Market Size Through 2029?

In the upcoming years, the lentiviral vector market is projected to undergo significant expansion, reaching $29.41 billion by 2029 with an annual compounded growth of 15.3%. This expected growth during the forecast period can be attributed to several factors such as an increase in personalized medicine, advancements in gene editing, a surge in demand for rare disease therapies, the adoption of lentiviral vector, financial backings in genomic medicine, and a concentrated focus on the scalability of manufacturing. Key trends anticipated for the future include the broadening of research and development, its integration into CAR-T cell therapy, the creation of next-generation vectors, its employment in the development of vaccines, and the advancement of production technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp

What are the Key Market Players in Lentiviral Vector Market and How They’re Evolving?

Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi

What Are the Primary Growth Drivers in the Lentiviral Vector Market?

The rise in chronic diseases is projected to fuel growth in the lentiviral vectors market. Chronic diseases are long duration health conditions that usually develop slowly and can persist for several years or even a lifetime. Factors such as growing elderly population, unhealthy lifestyles, urbanization, and environmental factors have led to an increase in chronic diseases. Lentiviral vectors provide adaptable and effective methods for creating vaccines and treatment approaches for chronic diseases, meeting untapped medical demands, and enhancing patient results. For example, data from the British Heart Foundation, a cardiovascular research charity in the UK, in September 2024 stated that nearly 7.6 million people in the UK suffer from heart and circulatory diseases. About 4 million men and 3.6 million women are living with these conditions. These diseases account for roughly 27% of all deaths in the UK, resulting in over 170,000 deaths each year, which is approximately 480 deaths per day or one death every three minutes. As such, the growing occurrence of chronic diseases is stimulating the expansion of the lentiviral vectors market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14742&type=smp

What Are the Leading Segments in the Global Lentiviral Vector Industry?

The lentiviral vector market covered in this report is segmented –

1) By Product Type: Kits, Reagents And Consumables

2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications

3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes

Subsegments:

1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits

2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors

What Are the Key Market Trends in the Lentiviral Vector Industry?

Key players in the lentiviral vectors market are concentrating on creating LV vector production platforms like LentiSure, with the aim of boosting the effectiveness and reliability of producing lentiviral vectors for cell-based immuno-oncology treatments. LentiSure, an LV vector production platform, is designed to elevate the generation efficiency and reliability of lentiviral vectors for cell-based immuno-oncology therapies. For instance, Yposkesi sk pharmteco, a viral vector manufacturing company in France introduced LentiSure in May 2023. This revolutionary platform aims to enhance lentiviral (LV) vector production, with an emphasis on improving the efficiency and resilience of producing lentiviruses. It caters to the increasing demand for sturdy and economically scalable viral-vector manufacturing technologies required for cell and gene therapies. With average titers at cell culture harvest at 10e7 IG/mL bioreactor volume, the platform assures consistent product quality with greater productivity and success for cell therapy developers.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report

What Is the Regional Outlook for the Lentiviral Vector Market?

North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14742

This Report Delivers Insight On:

1. How big is the lentiviral vector market, and how is it changing globally?

2. Who are the major companies in the lentiviral vector market, and how are they performing?

3. What are the key opportunities and risks in the lentiviral vector market right now?

4. Which products or customer segments are growing the most in the lentiviral vector market?

5. What factors are helping or slowing down the growth of the lentiviral vector market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model